NCT01550783View on ClinicalTrials.gov

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

NACompletedINTERVENTIONAL
Enrollment

1,335

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 16, 2017

Study Completion Date

November 16, 2017

Conditions
Atypical Squamous Cell of Undetermined SignificanceCervical CarcinomaCervical Intraepithelial Neoplasia Grade 2/3Health Status UnknownHuman Papillomavirus InfectionLow Grade Cervical Squamous Intraepithelial NeoplasiaStage 0 Cervical Cancer
Interventions
OTHER

Cervical Papanicolaou Test

Undergo standard of care Pap test screening

OTHER

Cytology Specimen Collection Procedure

Undergo home-based HPV screening

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Screening Method

Undergo standard of care Pap test screening

PROCEDURE

Screening Method

Undergo home-based HPV screening

Trial Locations (2)

55455

University of Minnesota/Masonic Cancer Center, Minneapolis

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT01550783 - Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening | Biotech Hunter | Biotech Hunter